MacroGenics
MGNX
154 hedge funds and large institutions have $1.21B invested in MacroGenics in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 43 increasing their positions, 59 reducing their positions, and 13 closing their positions.
390% more call options, than puts
Call options by funds: $11.8M | Put options by funds: $2.4M
38% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 13
3% more funds holding
Funds holding: 149 → 154 (+5)
0.56% less ownership
Funds ownership: 95.28% → 94.72% (-0.56%)
21% less capital invested
Capital invested by funds: $1.53B → $1.21B (-$318M)
27% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 59
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Top Buyers
| 1 |
RI
RTW Investments
New York
|
+$34.4M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$28.1M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
+$14M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$11.3M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$7.6M |
Top Sellers
| 1 |
Holocene Advisors
New York
|
-$40.3M |
| 2 |
CC
Commodore Capital
New York
|
-$10.6M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$9.12M |
| 4 |
State Street
Boston,
Massachusetts
|
-$6.96M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$6.53M |
MGNX Hedge Fund Activity: Q3 2021 in Review
154 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q3 2021, worth a combined $1.21B — down 21% from $1.53B a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new MGNX positions and 13 closed out — a net gain of 5 holders — while 43 added to existing stakes and 59 trimmed.
The largest buyer was RTW Investments, adding an estimated $34.4M. The largest seller was Holocene Advisors, exiting entirely with an estimated $40.3M sold.
- 154 institutional investors held MacroGenics (MGNX) as of Q3 2021, up from 149 in Q2 2021.
- Funds reported $1.21B of MacroGenics stock for Q3 2021, down 21% quarter-over-quarter.
- 18 funds opened new MacroGenics positions in Q3 2021 and 13 closed out, a net change of +5 holders.
- The largest MacroGenics buyer in Q3 2021 was RTW Investments, an estimated $34.4M added.
- The largest MacroGenics seller in Q3 2021 was Holocene Advisors, an estimated $40.3M sold.
Based on aggregated 13F filings for Q3 2021.